PET radiomics for histologic subtype classification of non-small cell lung cancer: a systematic review and meta-analysis

Purpose To systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung cancer (NSCLC). Methods PubMed, Embase, Scopus, and Web of Science databases were systematically searched in English on human subjects for studies...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of nuclear medicine and molecular imaging Vol. 52; no. 6; pp. 2212 - 2224
Main Authors Zhang, Jucheng, Zhang, Xiaohui, Zhong, Yan, Wang, Jing, Zhong, Chao, Xiao, Meiling, Chen, Yuhan, Zhang, Hong
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.05.2025
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN1619-7070
1619-7089
1619-7089
DOI10.1007/s00259-025-07069-6

Cover

Abstract Purpose To systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung cancer (NSCLC). Methods PubMed, Embase, Scopus, and Web of Science databases were systematically searched in English on human subjects for studies on distinguishing adenocarcinoma (ADC) from squamous cell carcinoma (SCC) using PET radiomics published from inception until November 2024. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool and the Radiomics Quality Score (RQS) were utilized to assess the methodological quality of the included studies. The area under the receiver operating characteristic curves (AUC) was pooled to estimate predictive performance. An overall effect size was estimated using a random-effects model. Statistical heterogeneity was evaluated by the I 2 value. Subgroup analyses were conducted to explore sources of heterogeneity. Results Twelve studies were included in the analysis, yielding a pooled AUC of 0.92 (95% confidence interval [CI]: 0.89–0.94). Despite this promising result, the studies showed limitations in both study design and methodological quality, as evidenced by a median RQS of 11/36. A significant degree of heterogeneity was observed among the studies, with an I 2 of 92.20% (95% CI: 89.01–95.39) for sensitivity and 89.29% (95% CI: 84.48–94.10) for specificity. Conclusions This meta-analysis highlights the potential utility of PET radiomics in distinguishing ADC from SCC. However, the observed high heterogeneity indicates substantial methodological variability across the included studies. Future research should focus on standardization, transparency, and multicenter collaborations to improve the reliability and clinical applicability of PET radiomics for histologic subtype classification in NSCLC.
AbstractList PurposeTo systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung cancer (NSCLC).MethodsPubMed, Embase, Scopus, and Web of Science databases were systematically searched in English on human subjects for studies on distinguishing adenocarcinoma (ADC) from squamous cell carcinoma (SCC) using PET radiomics published from inception until November 2024. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool and the Radiomics Quality Score (RQS) were utilized to assess the methodological quality of the included studies. The area under the receiver operating characteristic curves (AUC) was pooled to estimate predictive performance. An overall effect size was estimated using a random-effects model. Statistical heterogeneity was evaluated by the I2 value. Subgroup analyses were conducted to explore sources of heterogeneity.ResultsTwelve studies were included in the analysis, yielding a pooled AUC of 0.92 (95% confidence interval [CI]: 0.89–0.94). Despite this promising result, the studies showed limitations in both study design and methodological quality, as evidenced by a median RQS of 11/36. A significant degree of heterogeneity was observed among the studies, with an I2 of 92.20% (95% CI: 89.01–95.39) for sensitivity and 89.29% (95% CI: 84.48–94.10) for specificity.ConclusionsThis meta-analysis highlights the potential utility of PET radiomics in distinguishing ADC from SCC. However, the observed high heterogeneity indicates substantial methodological variability across the included studies. Future research should focus on standardization, transparency, and multicenter collaborations to improve the reliability and clinical applicability of PET radiomics for histologic subtype classification in NSCLC.
Purpose To systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung cancer (NSCLC). Methods PubMed, Embase, Scopus, and Web of Science databases were systematically searched in English on human subjects for studies on distinguishing adenocarcinoma (ADC) from squamous cell carcinoma (SCC) using PET radiomics published from inception until November 2024. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool and the Radiomics Quality Score (RQS) were utilized to assess the methodological quality of the included studies. The area under the receiver operating characteristic curves (AUC) was pooled to estimate predictive performance. An overall effect size was estimated using a random-effects model. Statistical heterogeneity was evaluated by the I 2 value. Subgroup analyses were conducted to explore sources of heterogeneity. Results Twelve studies were included in the analysis, yielding a pooled AUC of 0.92 (95% confidence interval [CI]: 0.89–0.94). Despite this promising result, the studies showed limitations in both study design and methodological quality, as evidenced by a median RQS of 11/36. A significant degree of heterogeneity was observed among the studies, with an I 2 of 92.20% (95% CI: 89.01–95.39) for sensitivity and 89.29% (95% CI: 84.48–94.10) for specificity. Conclusions This meta-analysis highlights the potential utility of PET radiomics in distinguishing ADC from SCC. However, the observed high heterogeneity indicates substantial methodological variability across the included studies. Future research should focus on standardization, transparency, and multicenter collaborations to improve the reliability and clinical applicability of PET radiomics for histologic subtype classification in NSCLC.
To systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung cancer (NSCLC). PubMed, Embase, Scopus, and Web of Science databases were systematically searched in English on human subjects for studies on distinguishing adenocarcinoma (ADC) from squamous cell carcinoma (SCC) using PET radiomics published from inception until November 2024. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool and the Radiomics Quality Score (RQS) were utilized to assess the methodological quality of the included studies. The area under the receiver operating characteristic curves (AUC) was pooled to estimate predictive performance. An overall effect size was estimated using a random-effects model. Statistical heterogeneity was evaluated by the I value. Subgroup analyses were conducted to explore sources of heterogeneity. Twelve studies were included in the analysis, yielding a pooled AUC of 0.92 (95% confidence interval [CI]: 0.89-0.94). Despite this promising result, the studies showed limitations in both study design and methodological quality, as evidenced by a median RQS of 11/36. A significant degree of heterogeneity was observed among the studies, with an I of 92.20% (95% CI: 89.01-95.39) for sensitivity and 89.29% (95% CI: 84.48-94.10) for specificity. This meta-analysis highlights the potential utility of PET radiomics in distinguishing ADC from SCC. However, the observed high heterogeneity indicates substantial methodological variability across the included studies. Future research should focus on standardization, transparency, and multicenter collaborations to improve the reliability and clinical applicability of PET radiomics for histologic subtype classification in NSCLC.
To systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung cancer (NSCLC).PURPOSETo systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung cancer (NSCLC).PubMed, Embase, Scopus, and Web of Science databases were systematically searched in English on human subjects for studies on distinguishing adenocarcinoma (ADC) from squamous cell carcinoma (SCC) using PET radiomics published from inception until November 2024. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool and the Radiomics Quality Score (RQS) were utilized to assess the methodological quality of the included studies. The area under the receiver operating characteristic curves (AUC) was pooled to estimate predictive performance. An overall effect size was estimated using a random-effects model. Statistical heterogeneity was evaluated by the I2 value. Subgroup analyses were conducted to explore sources of heterogeneity.METHODSPubMed, Embase, Scopus, and Web of Science databases were systematically searched in English on human subjects for studies on distinguishing adenocarcinoma (ADC) from squamous cell carcinoma (SCC) using PET radiomics published from inception until November 2024. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool and the Radiomics Quality Score (RQS) were utilized to assess the methodological quality of the included studies. The area under the receiver operating characteristic curves (AUC) was pooled to estimate predictive performance. An overall effect size was estimated using a random-effects model. Statistical heterogeneity was evaluated by the I2 value. Subgroup analyses were conducted to explore sources of heterogeneity.Twelve studies were included in the analysis, yielding a pooled AUC of 0.92 (95% confidence interval [CI]: 0.89-0.94). Despite this promising result, the studies showed limitations in both study design and methodological quality, as evidenced by a median RQS of 11/36. A significant degree of heterogeneity was observed among the studies, with an I2 of 92.20% (95% CI: 89.01-95.39) for sensitivity and 89.29% (95% CI: 84.48-94.10) for specificity.RESULTSTwelve studies were included in the analysis, yielding a pooled AUC of 0.92 (95% confidence interval [CI]: 0.89-0.94). Despite this promising result, the studies showed limitations in both study design and methodological quality, as evidenced by a median RQS of 11/36. A significant degree of heterogeneity was observed among the studies, with an I2 of 92.20% (95% CI: 89.01-95.39) for sensitivity and 89.29% (95% CI: 84.48-94.10) for specificity.This meta-analysis highlights the potential utility of PET radiomics in distinguishing ADC from SCC. However, the observed high heterogeneity indicates substantial methodological variability across the included studies. Future research should focus on standardization, transparency, and multicenter collaborations to improve the reliability and clinical applicability of PET radiomics for histologic subtype classification in NSCLC.CONCLUSIONSThis meta-analysis highlights the potential utility of PET radiomics in distinguishing ADC from SCC. However, the observed high heterogeneity indicates substantial methodological variability across the included studies. Future research should focus on standardization, transparency, and multicenter collaborations to improve the reliability and clinical applicability of PET radiomics for histologic subtype classification in NSCLC.
Author Zhang, Xiaohui
Zhong, Yan
Zhong, Chao
Xiao, Meiling
Zhang, Hong
Zhang, Jucheng
Chen, Yuhan
Wang, Jing
Author_xml – sequence: 1
  givenname: Jucheng
  surname: Zhang
  fullname: Zhang, Jucheng
  organization: Department of Clinical Engineering, The Second Affiliated Hospital of Zhejiang University School of Medicine, Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Medical Molecular Imaging of Zhejiang Province
– sequence: 2
  givenname: Xiaohui
  surname: Zhang
  fullname: Zhang, Xiaohui
  organization: Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Institute of Nuclear Medicine and Molecular, Imaging of Zhejiang University
– sequence: 3
  givenname: Yan
  surname: Zhong
  fullname: Zhong, Yan
  organization: Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Institute of Nuclear Medicine and Molecular, Imaging of Zhejiang University
– sequence: 4
  givenname: Jing
  surname: Wang
  fullname: Wang, Jing
  organization: Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Institute of Nuclear Medicine and Molecular, Imaging of Zhejiang University
– sequence: 5
  givenname: Chao
  surname: Zhong
  fullname: Zhong, Chao
  organization: Department of Radiology, Ningbo Yinzhou NO.2 Hospital
– sequence: 6
  givenname: Meiling
  surname: Xiao
  fullname: Xiao, Meiling
  organization: Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Institute of Nuclear Medicine and Molecular, Imaging of Zhejiang University
– sequence: 7
  givenname: Yuhan
  surname: Chen
  fullname: Chen, Yuhan
  organization: Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Institute of Nuclear Medicine and Molecular, Imaging of Zhejiang University
– sequence: 8
  givenname: Hong
  orcidid: 0000-0002-4084-5150
  surname: Zhang
  fullname: Zhang, Hong
  email: hzhang21@zju.edu.cn
  organization: Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Institute of Nuclear Medicine and Molecular, Imaging of Zhejiang University, Key Laboratory for Biomedical Engineering of Ministry of Education, Zhejiang University, College of Biomedical Engineering & Instrument Science, Zhejiang University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39794511$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1vFSEUxYmpsV_-Ay4MiRs32AvMwODONPUjaVIX7ZowDDxpZoYnd6b6_nt5vloTF24OLH4Hzr3nlBzNeQ6EvOLwjgPoCwQQrWFVGGhQhqln5IQrbpiGzhw93TUck1PEewDeic68IMfSaNO0nJ-Qn1-vbmlxQ8pT8khjLvRbwiWPeZM8xbVfdttA_egQU0zeLSnPNEdaozCc3DhSH6qM67yh3s0-lPfUUdzhEqYKe1rCQwo_qJsHOoXFMTe7cYcJz8nz6EYMLx_PM3L38er28jO7vvn05fLDNfNSqIV5IQbwDejBi25olYyaG3C85y42nTGtA-hdr1svlIja9X0djUevlWi8iFyekbeHd7clf18DLnZKuM_s5pBXtJK3TQOy7qaib_5B7_Naat49ZWSjFG9kpV4_Ums_hcFuS5pc2dk_O62AOAC-ZMQS4hPCwe6Ls4fibBX7uzirqkkeTFjheRPK37__4_oF6d2a-Q
Cites_doi 10.3322/caac.21834
10.1053/j.semnuclmed.2022.04.010
10.1016/j.mayocp.2019.01.013
10.1259/bjr.20220339
10.1007/s11307-016-0940-2
10.2147/CMAR.S287128
10.1136/bmj.315.7109.629
10.2967/jnumed.118.217612
10.1148/radiol.212798
10.1016/j.bspc.2021.102446
10.18383/j.tom.2019.00031
10.1007/s00259-022-06001-6
10.1016/j.compbiomed.2024.108461
10.1007/s00259-020-05065-6
10.1016/j.acra.2023.03.032
10.3389/fonc.2022.875761
10.1002/ima.22858
10.1007/s00259-017-3865-3
10.3389/fonc.2022.991102
10.1007/s00259-021-05220-7
10.1007/s00330-020-06957-9
10.1016/S1470-2045(20)30751-8
10.3389/fonc.2022.803824
10.3906/elk-1810-154
10.1109/JBHI.2022.3192010
10.1016/S1470-2045(20)30108-X
10.7326/0003-4819-155-8-201110180-00009
10.1109/ACCESS.2020.3040155
10.1007/s00330-017-5221-1
10.1097/JTO.0b013e318226b677
10.1088/1361-6560/aad648
10.1002/mp.13678
10.21203/rs.3.rs-2393890/v1
10.1634/theoncologist.2008-0232
10.1371/journal.pone.0300170
10.1038/nrclinonc.2017.141
10.1136/bmj.b605
10.1136/bmjopen-2021-056804
10.1038/s41591-021-01450-2
10.21037/tcr.2019.08.20
10.1016/j.clon.2023.08.003
10.1007/s00259-020-04771-5
10.21037/qims-20-1182
10.3389/fonc.2021.633176
10.1007/s11547-023-01621-w
10.1136/bmj.n160
10.1097/RLU.0000000000002810
10.1007/s00259-021-05234-1
10.3322/caac.21820
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2025 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Copyright Springer Nature B.V. May 2025
Copyright_xml – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2025 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
– notice: Copyright Springer Nature B.V. May 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
K9.
NAPCQ
7X8
DOI 10.1007/s00259-025-07069-6
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1619-7089
EndPage 2224
ExternalDocumentID 39794511
10_1007_s00259_025_07069_6
Genre Meta-Analysis
Systematic Review
Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 32027802
  funderid: http://dx.doi.org/10.13039/501100001809
– fundername: Key Research and Development Program of Zhejiang Province
  grantid: 2022C03071; 2022C03111; 2023C03088
  funderid: http://dx.doi.org/10.13039/100022963
– fundername: Fundamental Research Funds for the Central Universities
  grantid: Fundamental Research Funds for the Central Universities
  funderid: http://dx.doi.org/10.13039/501100012226
– fundername: Key Research and Development Program of Zhejiang Province
  grantid: 2023C03088
– fundername: National Natural Science Foundation of China
  grantid: 32027802
– fundername: Key Research and Development Program of Zhejiang Province
  grantid: 2022C03071
– fundername: Fundamental Research Funds for the Central Universities
  grantid: Fundamental Research Funds for the Central Universities
– fundername: Key Research and Development Program of Zhejiang Province
  grantid: 2022C03111
GroupedDBID ---
-Y2
-~C
.86
.GJ
04C
06C
06D
0R~
0VY
1N0
29G
29~
2JN
2JY
2LR
2P1
2VQ
2~H
36B
4.4
406
40D
53G
5GY
5QI
5RE
5VS
6NX
78A
7RV
7X7
88E
8AO
8FE
8FG
8FH
8FI
8FJ
8UJ
95-
95.
95~
AACDK
AAHNG
AAIAL
AAJBT
AANXM
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBRH
ABBXA
ABDBE
ABDBF
ABECU
ABFTV
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABLJU
ABMNI
ABMQK
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABUWZ
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHVE
ACIWK
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACUDM
ACUHS
ACZOJ
ADBBV
ADHIR
ADHKG
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AEVLU
AEXYK
AFBBN
AFDZB
AFEXP
AFFNX
AFJLC
AFKRA
AFLOW
AFOHR
AFQWF
AFRAH
AFWTZ
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGQPQ
AGRTI
AGVAE
AGWIL
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHPBZ
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMXSW
AMYLF
AOCGG
ARAPS
AXYYD
AYFIA
AZFZN
B-.
B0M
BA0
BBNVY
BDATZ
BENPR
BGLVJ
BGNMA
BHPHI
BKEYQ
BMSDO
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CSCUP
DDRTE
DNIVK
DPUIP
DU5
EAD
EAP
EAS
EBB
EBC
EBD
EBLON
EBO
EBS
EBX
EHN
EIHBH
EIOEI
EJD
EMB
EMK
EMOBN
EN4
EPL
EPT
ESX
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FSGXE
FYUFA
G-Y
G-Z
GGCAI
GNWQR
GQ7
GRRUI
H13
HCIFZ
HF~
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
IHE
IJ-
IKXTQ
IMOTQ
IWAJR
IZIGR
IZQ
I~X
I~Z
J-C
JBSCW
JCJTX
JZLTJ
KDC
KPH
LAS
LK8
LLZTM
M1P
M4Y
M7P
MA-
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O9G
OAM
OVD
P19
P62
P9S
PF0
PHGZT
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
Q~Q
R89
R9I
RNI
RNS
ROL
RPX
RSV
RZK
S1Z
S26
S27
S28
S37
SAP
SCLPG
SDH
SISQX
SJYHP
SMD
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
T13
T16
TEORI
TH9
TSG
TSK
TT1
TUS
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VFIZW
W23
W48
WK8
WOW
YLTOR
Z8Z
ZMTXR
~8M
AAYXX
ABFSG
ABRTQ
ACSTC
AEZWR
AFHIU
AHWEU
AIXLP
ATHPR
CITATION
PHGZM
PJZUB
PPXIY
PQGLB
PUEGO
CGR
CUY
CVF
ECM
EIF
NPM
7TK
K9.
7X8
ID FETCH-LOGICAL-c326t-c22d0c407dc28d563f7190a1b1af48995a00bab75c262f7abb9791fc7624c2f13
ISSN 1619-7070
1619-7089
IngestDate Fri Sep 05 06:50:04 EDT 2025
Sat Aug 16 21:26:10 EDT 2025
Wed Jul 30 01:49:28 EDT 2025
Wed Oct 01 08:24:31 EDT 2025
Wed Apr 23 01:18:06 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Positron emission tomography (PET)
NSCLC
Histologic subtype
Radiomics
Language English
License 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c326t-c22d0c407dc28d563f7190a1b1af48995a00bab75c262f7abb9791fc7624c2f13
Notes ObjectType-Article-1
ObjectType-Evidence Based Healthcare-3
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-4084-5150
PMID 39794511
PQID 3193466143
PQPubID 42802
PageCount 13
ParticipantIDs proquest_miscellaneous_3154403001
proquest_journals_3193466143
pubmed_primary_39794511
crossref_primary_10_1007_s00259_025_07069_6
springer_journals_10_1007_s00259_025_07069_6
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-05-01
PublicationDateYYYYMMDD 2025-05-01
PublicationDate_xml – month: 05
  year: 2025
  text: 2025-05-01
  day: 01
PublicationDecade 2020
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Heidelberg
PublicationTitle European journal of nuclear medicine and molecular imaging
PublicationTitleAbbrev Eur J Nucl Med Mol Imaging
PublicationTitleAlternate Eur J Nucl Med Mol Imaging
PublicationYear 2025
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References F Bray (7069_CR2) 2024; 74
Y Zhang (7069_CR24) 2024; 19
C Owens (7069_CR9) 2023; 96
X Tang (7069_CR17) 2022; 12
7069_CR36
H Li (7069_CR48) 2022; 26
M Tian (7069_CR8) 2021; 48
I Fornacon-Wood (7069_CR41) 2020; 30
X Sun (7069_CR13) 2022; 12
PF Whiting (7069_CR30) 2011; 155
Z Diao (7069_CR45) 2024; 174
Y Ji (7069_CR46) 2021; 13
L Papp (7069_CR43) 2019; 60
A Civelek (7069_CR50) 2017; 58
X Sha (7069_CR19) 2019; 8
X Zhu (7069_CR6) 2018; 28
B Zhao (7069_CR39) 2021; 11
H Zhao (7069_CR32) 2022; 12
MA Leger (7069_CR10) 2022; 52
K Barbouchi (7069_CR28) 2023; 33
SH Hyun (7069_CR20) 2019; 44
O Ayyildiz (7069_CR21) 2020; 28
C Ren (7069_CR16) 2021; 48
C Faivre-Finn (7069_CR11) 2020; 21
M Hatt (7069_CR35) 2023; 50
M Avanzo (7069_CR42) 2020; 47
WM Chen (7069_CR12) 2022; 305
7069_CR1
7069_CR3
M Egger (7069_CR31) 1997; 315
A Civelek (7069_CR51) 2017; 58
CH Chiu (7069_CR14) 2011; 6
M McNitt-Gray (7069_CR40) 2020; 6
M Bicakci (7069_CR44) 2020; 8
M Wang (7069_CR4) 2021; 27
H Shen (7069_CR18) 2021; 11
P Lambin (7069_CR15) 2017; 14
Y Ma (7069_CR23) 2018; 63
Y Zhou (7069_CR25) 2021; 48
H Zhao (7069_CR27) 2024; 31
K Chen (7069_CR47) 2023; 128
MJ Page (7069_CR29) 2021; 372
E Bębas (7069_CR34) 2021; 66
Z Khodabakhshi (7069_CR22) 2023; 35
FH van Velden (7069_CR38) 2016; 18
Y Han (7069_CR26) 2021; 48
H Hricak (7069_CR7) 2021; 22
DG Altman (7069_CR49) 2009; 338
M Hatt (7069_CR37) 2018; 45
X Tang (7069_CR33) 2022; 12
G Scagliotti (7069_CR5) 2009; 14
References_xml – volume: 74
  start-page: 229
  year: 2024
  ident: 7069_CR2
  publication-title: CA: Cancer J Clin
  doi: 10.3322/caac.21834
– volume: 52
  start-page: 707
  year: 2022
  ident: 7069_CR10
  publication-title: Semin Nucl Med
  doi: 10.1053/j.semnuclmed.2022.04.010
– ident: 7069_CR3
  doi: 10.1016/j.mayocp.2019.01.013
– volume: 96
  start-page: 20220339
  year: 2023
  ident: 7069_CR9
  publication-title: Br J Radiol
  doi: 10.1259/bjr.20220339
– volume: 18
  start-page: 788
  year: 2016
  ident: 7069_CR38
  publication-title: Mol Imaging Biol
  doi: 10.1007/s11307-016-0940-2
– volume: 13
  start-page: 307
  year: 2021
  ident: 7069_CR46
  publication-title: Cancer Manag Res
  doi: 10.2147/CMAR.S287128
– volume: 315
  start-page: 629
  year: 1997
  ident: 7069_CR31
  publication-title: BMJ
  doi: 10.1136/bmj.315.7109.629
– volume: 60
  start-page: 864
  year: 2019
  ident: 7069_CR43
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.118.217612
– volume: 305
  start-page: 219
  year: 2022
  ident: 7069_CR12
  publication-title: Radiology
  doi: 10.1148/radiol.212798
– volume: 66
  start-page: 102446
  year: 2021
  ident: 7069_CR34
  publication-title: Biomed Signal Process Control
  doi: 10.1016/j.bspc.2021.102446
– volume: 6
  start-page: 118
  year: 2020
  ident: 7069_CR40
  publication-title: Tomography
  doi: 10.18383/j.tom.2019.00031
– volume: 50
  start-page: 352
  year: 2023
  ident: 7069_CR35
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-022-06001-6
– volume: 174
  start-page: 108461
  year: 2024
  ident: 7069_CR45
  publication-title: Comput Biol Med
  doi: 10.1016/j.compbiomed.2024.108461
– volume: 48
  start-page: 1538
  year: 2021
  ident: 7069_CR16
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-020-05065-6
– volume: 31
  start-page: 35
  year: 2024
  ident: 7069_CR27
  publication-title: Acad Radiol
  doi: 10.1016/j.acra.2023.03.032
– volume: 12
  start-page: 875761
  year: 2022
  ident: 7069_CR32
  publication-title: Front Oncol
  doi: 10.3389/fonc.2022.875761
– volume: 33
  start-page: 1383
  year: 2023
  ident: 7069_CR28
  publication-title: Int J Imaging Syst Technol
  doi: 10.1002/ima.22858
– volume: 45
  start-page: 630
  year: 2018
  ident: 7069_CR37
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-017-3865-3
– volume: 12
  start-page: 991102
  year: 2022
  ident: 7069_CR17
  publication-title: Front Oncol
  doi: 10.3389/fonc.2022.991102
– volume: 48
  start-page: 2904
  year: 2021
  ident: 7069_CR25
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-021-05220-7
– volume: 30
  start-page: 6241
  year: 2020
  ident: 7069_CR41
  publication-title: Eur Radiol
  doi: 10.1007/s00330-020-06957-9
– volume: 22
  start-page: e136
  year: 2021
  ident: 7069_CR7
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(20)30751-8
– volume: 12
  start-page: 803824
  year: 2022
  ident: 7069_CR33
  publication-title: Front Oncol
  doi: 10.3389/fonc.2022.803824
– volume: 28
  start-page: 262
  year: 2020
  ident: 7069_CR21
  publication-title: Turk J Electr Eng Co
  doi: 10.3906/elk-1810-154
– volume: 26
  start-page: 4563
  year: 2022
  ident: 7069_CR48
  publication-title: IEEE J Biomed Health Inf
  doi: 10.1109/JBHI.2022.3192010
– volume: 21
  start-page: 481
  year: 2020
  ident: 7069_CR11
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(20)30108-X
– volume: 155
  start-page: 529
  year: 2011
  ident: 7069_CR30
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-155-8-201110180-00009
– volume: 8
  start-page: 218470
  year: 2020
  ident: 7069_CR44
  publication-title: IEEE Access
  doi: 10.1109/ACCESS.2020.3040155
– volume: 28
  start-page: 2772
  year: 2018
  ident: 7069_CR6
  publication-title: Eur Radiol
  doi: 10.1007/s00330-017-5221-1
– volume: 6
  start-page: 1697
  year: 2011
  ident: 7069_CR14
  publication-title: J Thorac Oncol
  doi: 10.1097/JTO.0b013e318226b677
– volume: 63
  start-page: 165018
  year: 2018
  ident: 7069_CR23
  publication-title: Phys Med Biol
  doi: 10.1088/1361-6560/aad648
– volume: 47
  start-page: e185
  year: 2020
  ident: 7069_CR42
  publication-title: Med Phys
  doi: 10.1002/mp.13678
– ident: 7069_CR36
  doi: 10.21203/rs.3.rs-2393890/v1
– volume: 14
  start-page: 253
  year: 2009
  ident: 7069_CR5
  publication-title: Oncologist
  doi: 10.1634/theoncologist.2008-0232
– volume: 58
  start-page: 1343
  issue: supplement 1
  year: 2017
  ident: 7069_CR50
  publication-title: J Nucl Med
– volume: 19
  start-page: e0300170
  year: 2024
  ident: 7069_CR24
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0300170
– volume: 58
  start-page: 455
  issue: supplement 1
  year: 2017
  ident: 7069_CR51
  publication-title: J Nucl Med
– volume: 14
  start-page: 749
  year: 2017
  ident: 7069_CR15
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/nrclinonc.2017.141
– volume: 338
  start-page: b605
  year: 2009
  ident: 7069_CR49
  publication-title: BMJ
  doi: 10.1136/bmj.b605
– volume: 12
  start-page: e056804
  year: 2022
  ident: 7069_CR13
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2021-056804
– volume: 27
  start-page: 1345
  year: 2021
  ident: 7069_CR4
  publication-title: Nat Med
  doi: 10.1038/s41591-021-01450-2
– volume: 8
  start-page: 1741
  year: 2019
  ident: 7069_CR19
  publication-title: Transl Cancer Res
  doi: 10.21037/tcr.2019.08.20
– volume: 35
  start-page: 713
  year: 2023
  ident: 7069_CR22
  publication-title: Clin Oncol
  doi: 10.1016/j.clon.2023.08.003
– volume: 48
  start-page: 350
  year: 2021
  ident: 7069_CR26
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-020-04771-5
– volume: 11
  start-page: 2918
  year: 2021
  ident: 7069_CR18
  publication-title: Quant Imaging Med Surg
  doi: 10.21037/qims-20-1182
– volume: 11
  start-page: 633176
  year: 2021
  ident: 7069_CR39
  publication-title: Front Oncol
  doi: 10.3389/fonc.2021.633176
– volume: 128
  start-page: 537
  year: 2023
  ident: 7069_CR47
  publication-title: Radiol Med
  doi: 10.1007/s11547-023-01621-w
– volume: 372
  start-page: n160
  year: 2021
  ident: 7069_CR29
  publication-title: BMJ
  doi: 10.1136/bmj.n160
– volume: 44
  start-page: 956
  year: 2019
  ident: 7069_CR20
  publication-title: Clin Nucl Med
  doi: 10.1097/RLU.0000000000002810
– volume: 48
  start-page: 2338
  year: 2021
  ident: 7069_CR8
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-021-05234-1
– ident: 7069_CR1
  doi: 10.3322/caac.21820
SSID ssj0018289
Score 2.463022
SecondaryResourceType review_article
Snippet Purpose To systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung...
To systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung cancer...
PurposeTo systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung cancer...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 2212
SubjectTerms Adenocarcinoma
Carcinoma, Non-Small-Cell Lung - classification
Carcinoma, Non-Small-Cell Lung - diagnostic imaging
Carcinoma, Non-Small-Cell Lung - pathology
Cardiology
Classification
Confidence intervals
Heterogeneity
Humans
Image Processing, Computer-Assisted - methods
Imaging
Lung cancer
Lung Neoplasms - classification
Lung Neoplasms - diagnostic imaging
Lung Neoplasms - pathology
Medicine
Medicine & Public Health
Meta-analysis
Non-small cell lung carcinoma
Nuclear Medicine
Oncology
Orthopedics
Positron-Emission Tomography
Quality assessment
Quality control
Radiology
Radiomics
Review Article
Small cell lung carcinoma
Squamous cell carcinoma
Statistical analysis
Statistical models
Subgroups
Title PET radiomics for histologic subtype classification of non-small cell lung cancer: a systematic review and meta-analysis
URI https://link.springer.com/article/10.1007/s00259-025-07069-6
https://www.ncbi.nlm.nih.gov/pubmed/39794511
https://www.proquest.com/docview/3193466143
https://www.proquest.com/docview/3154403001
Volume 52
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1619-7089
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0018289
  issn: 1619-7070
  databaseCode: AFBBN
  dateStart: 19970101
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdZCmMvY9_L1g0N9uap2LJsx3trR0sptOwhZdmTkWSbBZpkJDaM_aP7d3YnyXZcN7DuRSSKkBXdz6e7030Q8nEaBgVIxYLloZAMTijBFA9CpiIsb1yAiCAwwPnyKj6_FhfzaD4a_dnxWqordaR_3xlX8j9UhT6gK0bJ3oOy7aTQAZ-BvtAChaH9Jxp_PZ15G5kvMLLY5FWw6YMNO_O2tTL2VY3yMToEtcIhaPxsu8Q7aTTbezc1xt0i9Tc29Pl2dmfrNLwsKsmky2Gy16DvhNsVpkmWm_bq3s7QlOL1FktTHGlgtb6oAUN39M8Xcv2jXnT9zpH4e4ftb80UzbzOlMGjznGwZ8r09mX6QgYNCh9LfFts5KjY7bOliBquHvEd9PZYNHd-24X7amO4B0eJ9R7Bql1RysxiEz9O2a283a0iZVI_m8EZNJkZnMUPyAFPYpGMycHx2cnJVXvBhYou2gKav-PiuUxU5-CRfZlpoAgNLvGNbDR7Qh47pYYeW4Q-JaNi9Yw8vHS0f05-AVBpC1QKQKUdUKkDKu0Dla5L2gKVIlApApVaoH6mknYwpRamFEBGezB9Qa7PTmdfzpkr-cE06BEV05znvhZ-kms-zaM4LBOQWGWgAlmKaZpG0veVVEmkeczLRCqVJmlQajjSheZlEL4kY1hb8ZrQWJcqLHmai4SLSObSL6epymOlQ1Qz-IR4zaZmP21ml2w_ISfksNn3zL1N2wyOr1CggBtOyIf2Z-DPuClyVaxrHINcLwSST8grS6_2cXinjvkBJ-RTQ8Bu8v1reXO_4W_Jo-5lOyTjalMX70CSrtR7h8q_mc3HYQ
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PET+radiomics+for+histologic+subtype+classification+of+non-small+cell+lung+cancer%3A+a+systematic+review+and+meta-analysis&rft.jtitle=European+journal+of+nuclear+medicine+and+molecular+imaging&rft.au=Zhang%2C+Jucheng&rft.au=Zhang%2C+Xiaohui&rft.au=Zhong%2C+Yan&rft.au=Wang%2C+Jing&rft.date=2025-05-01&rft.pub=Springer+Berlin+Heidelberg&rft.issn=1619-7070&rft.eissn=1619-7089&rft.volume=52&rft.issue=6&rft.spage=2212&rft.epage=2224&rft_id=info:doi/10.1007%2Fs00259-025-07069-6&rft.externalDocID=10_1007_s00259_025_07069_6
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1619-7070&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1619-7070&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1619-7070&client=summon